Study of liver disease with sepsis
Part of Infections clinical trials.
This study follows people with chronic liver disease who develop a serious infection called sepsis. The goal is to learn more about how to better treat or manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cirrhosis (a type of liver scarring).
- You have a confirmed infection that caused sepsis (a serious reaction to infection).
- You have not had an organ transplant or an active cancer.
- You are not pregnant or breastfeeding.
- You are not taking certain long-term medications that weaken your immune system (except for steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study analyzes gene activity in patients with severe liver failure or sepsis to understand why some recover and others don't. It may lead to better treatments in the future.
This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This study looks at different types (“endotypes”) of sepsis in adults to better understand what’s happening in the body and how patients may respond. You might be asked to provide information and samples as the study tries to sort sepsis into meaningful subgroups.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.